Free Newsletter
Group firebombs another UCLA researcher's car
A vehicle belonging to a university researcher at UCLA was firebombed recently, the latest in a string of attacks carried out by members of a radical animal-rights group. Police and the university condemned the attacked, and boosted their reward for information about the attackers to $445,000.
"The actions of extremists who use violent and illegal tactics are utterly reprehensible and beyond contempt," Chancellor Gene Block said in a statement. The attack was quickly credited to the Animal Liberation Front, which said they would continue to target the researcher until he suspended his work involving animals.
There have been four firebombings at researchers' houses over the past year, destroying four vehicles and damaging the front door of one of the homes. Police have been stepping up their security efforts in a drive to arrest the animal rightists involved. But so far they have not met with success.
- read the report from the Daily Bruin
Related Articles:
Animal rights activists firebomb researchers' house, car
Protesters target the homes of research scientists
U.K. animal rights activist impact R&D
Comments
We as a govt. need to do somthing about these people who take the law into their own hands. They need to be made an example of to show these type of people that this is not right.
We all know who did this type of crime,it is the ARA or the PETA or the HSUS. If you read the law it stats that a hate crime is considered a crime and punishable with jail, fine ,probation. WE need to nip it in the bud!
These wackos need to be stopped. And anyone involved is this type of terrorism should be denied access to any drug or procedure developed using animals in research. Maybe when one of them dies for the cause, the rest of them will have gain a little common sense and decency. Then again, I doubt it.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: